Metastatic melanoma cells that have spread to lymph nodes survive by relying on a protein called ferroptosis suppressor ...

Neuroblastoma RAS viral oncogene homolog (NRAS)-mutant melanoma is an aggressive form of skin cancer that develops because of ...

New research from Moffitt Cancer Center shows that RAS(ON) multi-selective inhibition can directly block tumor growth and ...

NEO-CYT is a randomized, multi-centre trial of neoadjuvant MDNA11 (before curative intent surgery) sponsored by the Fondazione Melanoma Onlus, ...

Patients with uveal melanoma may respond to T-cell therapy directed at an antigen that is highly expressed in the tumors, ...

Medicenna Therapeutics Corp has announced a collaboration with Fondazione Melanoma Onlus to conduct the NEO-CYT trial, which will evaluate MDNA11, a next-generation IL-2 Superkine, as a neoadjuvant ...

Recall, at the 2025 SNO/ASCO CNS Metastases conference in August, ReSPECT-LM Phase 1 single dose escalation trial data showed: REYOBIQ produced a clinical benefit rate of over 75% in 3 clinically ...

New research from Moffitt Cancer Center shows that RAS(ON) multi-selective inhibition can directly block tumor growth and ...

The first-of-its-kind study shows that adding a small molecule that blocks the problematic protein to existing cancer ...

A gene mutation known to develop into one of Queensland’s deadliest cancers could be hiding in skin undetected.

A study led by UCLA Health Jonsson Comprehensive Cancer Center investigators reveals how melanoma, the deadliest form of skin ...